Close Menu

NEW YORK (360Dx) – Fujirebio Diagnostics said today that it has received US Food and Drug Administration clearance for use of its Lumipulse G BRAHMS PCT Assay for testing on the Lumipulse G1200 immunoassay platform. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.